ARSTX
Price
$18.57
Change
-$0.12 (-0.64%)
Updated
Jul 2 closing price
Net Assets
421.93M
VSMAX
Price
$143.98
Change
-$0.42 (-0.29%)
Updated
Jul 2 closing price
Net Assets
182.65B
Interact to see
Advertisement

ARSTX vs VSMAX

ARSTX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
ARSTX vs. VSMAX commentary
Jul 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSTX is a StrongBuy and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 183B vs. ARSTX (422M). VSMAX pays higher dividends than ARSTX: VSMAX (1.18) vs ARSTX (0.11). ARSTX was incepted earlier than VSMAX: ARSTX (34 years) vs VSMAX (26 years). ARSTX (1.06) is less costly to investors than VSMAX (0.05). ARSTX is a more actively managed with annual turnover of: 76.00 vs. VSMAX (17.00). VSMAX has a lower initial minimum investment than ARSTX: VSMAX (3000) vs ARSTX (100000). VSMAX (24.74) and ARSTX (24.13) have marching annual gain over last year. VSMAX return over 5 years is better than : 35.21 vs. ARSTX (17.35).
ARSTXVSMAXARSTX / VSMAX
Total Expense Ratio0.950.051,900%
Annual Report Gross Expense Ratio1.060.052,120%
Fund Existence34 years26 years-
Gain YTD15.55716.69693%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets422M183B0%
Annual Yield % from dividends0.111.189%
Returns for 1 year24.1324.7498%
Returns for 3 years52.0552.19100%
Returns for 5 years17.3535.2149%
Returns for 10 years73.77168.9244%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGMB12.650.78
+6.57%
Agomab Therapeutics NV
NBIX174.266.49
+3.87%
Neurocrine Biosciences
TR40.780.74
+1.85%
Tootsie Roll Industries Inc
ULBI6.11-0.14
-2.32%
Ultralife Corp
LUCY0.76-0.03
-3.81%
Innovative Eyewear Inc.